Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Exp Immunol ; 167(2): 269-74, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22236003

RESUMEN

The activation of nuclear factor-kappa B (NF-κB) in vascular endothelial cells may be involved in vascular pathogeneses such as vasculitis or atherosclerosis. Recently, it has been reported that some amino acids exhibit anti-inflammatory effects. We investigated the inhibitory effects of a panel of amino acids on cytokine production or expression of adhesion molecules that are involved in inflammatory diseases in various cell types. The activation of NF-κB was determined in human coronary arterial endothelial cells (HCAECs) because NF-κB modulates the production of many cytokines and the expression of adhesion molecules. We examined the inhibitory effects of the amino acids cysteine, histidine and glycine on the induction of NF-κB activation, expression of CD62E (E-selectin) and the production of interleukin (IL)-6 in HCAECs stimulated with tumour necrosis factor (TNF)-α. Cysteine, histidine and glycine significantly reduced NF-κB activation and inhibitor κBα (IκBα) degradation in HCAECs stimulated with TNF-α. Additionally, all the amino acids inhibited the expression of E-selectin and the production of IL-6 in HCAECs, and the effects of cysteine were the most significant. Our results show that glycine, histidine and cysteine can inhibit NF-κB activation, IκBα degradation, CD62E expression and IL-6 production in HCAECs, suggesting that these amino acids may exhibit anti-inflammatory effects during endothelial inflammation.


Asunto(s)
Antiinflamatorios/farmacología , Arteritis/prevención & control , Vasos Coronarios/citología , Cisteína/farmacología , Células Endoteliales/efectos de los fármacos , Glicina/farmacología , Histidina/farmacología , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Evaluación Preclínica de Medicamentos , Selectina E/biosíntesis , Selectina E/genética , Células Endoteliales/metabolismo , Endotelio Vascular/citología , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Proteínas I-kappa B/metabolismo , Interleucina-6/biosíntesis , Interleucina-6/genética , Inhibidor NF-kappaB alfa , FN-kappa B/metabolismo , Factor de Necrosis Tumoral alfa/farmacología
2.
Lett Appl Microbiol ; 49(1): 136-41, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19413761

RESUMEN

AIMS: To investigate hydrogen peroxide production by lactic acid bacteria (LAB) and to determine the key factors involved. METHODS AND RESULTS: Six strains of Weissella cibaria produced large amounts (2.2-3.2 mmol l(-1)) of hydrogen peroxide in GYP broth supplemented with sodium acetate, but very low accumulations in glucose yeast peptone broth without sodium acetate. Increased production of hydrogen peroxide was also recorded when strains of W. cibaria were cultured in the presence of potassium acetate, sodium isocitrate and sodium citrate. Oxidases and peroxidases were not detected, or were present at low levels in W. cibaria. However, strong nicotinamide adenine dinucleotide (NADH) oxidase activity was recorded, suggesting that the enzyme plays a key role in production of hydrogen peroxide by W. cibaria. CONCLUSIONS: Weissella cibaria produces large quantities of hydrogen peroxide in aerated cultures, in a process that is dependent on the presence of acetate in the culture medium. NADH oxidase is likely the key enzyme in this process. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first study showing that sodium acetate, normally present in culture media of LAB, is a key factor for hydrogen peroxide production by W. cibaria. The exact mechanisms involved are not known.


Asunto(s)
Bacterias Grampositivas/metabolismo , Peróxido de Hidrógeno/metabolismo , Acetato de Sodio/metabolismo , Aerobiosis , Citratos/metabolismo , Medios de Cultivo/química , Complejos Multienzimáticos/metabolismo , NADH NADPH Oxidorreductasas/metabolismo , Acetato de Potasio/metabolismo , Citrato de Sodio
3.
Hum Exp Toxicol ; 27(3): 207-14, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18650252

RESUMEN

We have evaluated the effect of dietary antioxidant, antioxidant biofactor (a processed grain food), on iron nitrilotriacetate-induced renal tumorigenesis, hyperproliferative response, and oxidative damage. In tumorigenesis studies, iron nitrilotriacetate alone treatment resulted in a development of 75% renal cell tumor incidence, whereas, in the group of animals fed with antioxidant biofactor diet and treated with iron nitrilotriacetate, only 43% of renal cell tumor incidence was observed. In oxidative damage studies, the decrease in the level of renal glutathione and antioxidant enzymes induced by iron nitrilotriacetate was significantly reversed by antioxidant biofactor diet pretreatment in a dose-dependent manner (18-71% recovery, P < 0.05). Antioxidant biofactor diet pretreatment also resulted in a dose-dependent inhibition (35-49% inhibition, P < 0.05) of iron nitrilotriacetate-induced lipid peroxidation as measured by thiobarbituric acid reactive substances formation in renal tissues. Similarly, in hyperproliferation studies, antioxidant biofactor diet pretreatment showed a strong inhibition of iron nitrilotriacetate-induced renal ornithine decarboxylase activity (18-54% inhibition, P < 0.05). In addition, antioxidant biofactor fed diet pretreatment also protected the kidney tissues against observed histopathological alterations. From this data, it can be concluded that antioxidant biofactor diet can abrogate the toxic and tumor promoting effects of iron nitrilotriacetate and can serve as a potent chemopreventive agent to suppress oxidant-induced tissue injury and tumorigenesis.


Asunto(s)
Compuestos Férricos/toxicidad , Neoplasias Renales/prevención & control , Ácido Nitrilotriacético/análogos & derivados , Fenoles/farmacología , Extractos Vegetales/farmacología , Animales , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Neoplasias Renales/inducido químicamente , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ácido Nitrilotriacético/toxicidad , Inhibidores de la Ornitina Descarboxilasa , Oxidación-Reducción , Ratas , Ratas Wistar
4.
Eur J Clin Nutr ; 61(3): 375-81, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16969379

RESUMEN

OBJECTIVE: Elderly patients often have impaired taste, nausea, anorexia and delayed healing of decubitus. In many of these patients, serum zinc levels are low and they respond to zinc supplementation. To date, no epidemics of zinc deficiency have been reported in Japan. We studied the prevalence of zinc deficiency and its causative factors in a typical local town in Japan. DESIGN: Cross-sectional study. SETTING: Nagano Prefecture (central Japan). SUBJECTS AND METHODS: Serum zinc levels were measured in 1009 habitants (18-96 years old) who participated in an annual mass health examination program of the City in 2003. Of all subjects, 86 with low serum zinc (<65 microg/dl) or high zinc (> or =90 microg/dl) levels were randomly selected, and a dietary survey using 24-h recalling methods for 2 consecutive days was performed in 2004. Among them, blood was collected in the morning from 50 subjects (26-94 years old). RESULTS: The percentage of those with low serum zinc levels (2.5th percentile of Americans) was 37.9% in the elderly (> or =60 years old). The age-adjusted prevalence of low serum zinc was 21.1% in the aged population. A positive correlation was detected between zinc intake and serum zinc levels in elderly subjects (> or =60 years old). CONCLUSIONS: The possibility of zinc deficiency in adult inhabitants in central Japan rises with age. The deficiency correlates with dietary zinc intake.


Asunto(s)
Enfermedades Carenciales/epidemiología , Dieta , Oligoelementos/sangre , Oligoelementos/deficiencia , Zinc/sangre , Zinc/deficiencia , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios Transversales , Enfermedades Carenciales/etiología , Dieta/normas , Ingestión de Energía/fisiología , Femenino , Encuestas Epidemiológicas , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Oligoelementos/administración & dosificación , Zinc/administración & dosificación
5.
Clin Exp Immunol ; 129(1): 43-53, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12100021

RESUMEN

Leucocytes infiltrate into renal tissue and are involved in the pathogenesis of crescentic glomerulonephritis. The initial event in the process of leucocyte infiltration is characterized by selectin-mediated leucocyte rolling on endothelial surface. Role of selectins in pathogenesis of glomerulonephritis has still been controversial. Sulphated glycolipids and sulphated polysaccharides interfere with the binding of P- and L-selectin with carbohydrate ligands on endothelial cells or on leucocytes. Here we evaluated the role of selectins and the preventive effects of sulphated colominic acid (SCA), a synthetic sulphated polysaccharide, on experimental crescentic glomerulonephritis in Wistar-Kyoto (WKY) rats. Crescentic glomerulonephritis was induced by injection of nephrotoxic serum (NTS) in WKY rats. Rats subsequently received intraperitoneal injection of saline, neutralizing or non-neutralizing monoclonal antibody (mAb) to rat P-selectin and L-selectin, SCA (5 or 10mg/kg/day) or nonsulphated colominic acid (CA) (10mg/kg/day) for 2 weeks. Localization of P-, E-selectin, ligands for L-selectin and intraglomerular leucocytes was examined by immunohistochemistry. Gene expression of platelet-derived growth factor (PDGF) B chain in glomeruli was quantified using real-time RT-PCR. P-selectin was highly expressed on glomerular endothelial cells after injection of NTS, whereas E-selectin and L-selectin ligands were not detected. Anti-P-selectin mAb, but not anti-L-selectin mAb, significantly reduced glomerular infiltration of macrophages, crescent formation, and proteinuria. SCA also reduced proteinuria, macrophage infiltration, and crescent formation in a dose-dependent manner. Furthermore, SCA suppressed gene expression of PDGF B chain in glomeruli. Our results indicate that P-selectin partially mediates glomerular infiltration of macrophage in experimental crescentic glomerulonephritis. Moreover, SCA may inhibit intraglomerular infiltration of macrophages by interfering with P-selectin-dependent adhesion pathway, and progression of experimental crescentic glomerulonephritis.


Asunto(s)
Glomerulonefritis/prevención & control , Macrófagos/efectos de los fármacos , Selectina-P/fisiología , Polisacáridos/uso terapéutico , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Adhesión Celular/efectos de los fármacos , Quimiotaxis de Leucocito , Evaluación Preclínica de Medicamentos , Selectina E/inmunología , Selectina E/fisiología , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Glomerulonefritis/etiología , Glomerulonefritis/patología , Inmunoglobulina G/toxicidad , Molécula 1 de Adhesión Intercelular/metabolismo , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/metabolismo , Selectina L/inmunología , Selectina L/fisiología , Macrófagos/fisiología , Ratones , Estructura Molecular , Selectina-P/biosíntesis , Selectina-P/genética , Selectina-P/inmunología , Reacción en Cadena de la Polimerasa , Polisacáridos/farmacología , Unión Proteica/efectos de los fármacos , Proteinuria/etiología , Proteinuria/prevención & control , Proteínas Proto-Oncogénicas c-sis/biosíntesis , Proteínas Proto-Oncogénicas c-sis/genética , Ratas , Ratas Endogámicas WKY
6.
Biochem Biophys Res Commun ; 289(2): 414-20, 2001 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-11716489

RESUMEN

Tec is the prototype of an emerging family of protein-tyrosine kinases. Tec and Btk, another member of this family, together participate in the development of B-cell immune system. We previously identified one of the downstream messengers for human Tec kinase, BRDG1. BRDG1 is associated with Tec and becomes tyrosine-phosphorylated in B-cells by the engagement of B-cell antigen receptor (BCR). Here we show that overexpression of BRDG1 strongly augments BCR-mediated activation of cAMP-response element binding protein (CREB) but not that of c-Jun and the promoters of c-MYC and BCL-xL genes. Furthermore, we isolated the murine orthologue of BRDG1. Three isoforms of BRDG1 are generated by alternative splicing of the message. Two of them have a deletion of 33 amino acids in a Pleckstrin homology (PH) domain of BRDG1. Both the tyrosine-phosphorylation and CREB-activating ability of BRDG1 were isoform-dependent, suggesting a role of the PH domain of BRDG1. These data have identified a novel regulatory mechanism of CREB family of transcriptional factors.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Proteínas Portadoras/química , Proteínas Portadoras/metabolismo , Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas/metabolismo , Empalme Alternativo , Secuencia de Aminoácidos , Animales , Northern Blotting , Línea Celular , AMP Cíclico/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , ADN Complementario/metabolismo , Eliminación de Gen , Genes myc/genética , Humanos , Inmunoglobulina M/inmunología , Ratones , Ratones Endogámicos C57BL , Modelos Biológicos , Datos de Secuencia Molecular , Fosforilación , Plásmidos/metabolismo , Regiones Promotoras Genéticas , Unión Proteica , Isoformas de Proteínas , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-jun/genética , Receptores de Antígenos de Linfocitos B/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal , Distribución Tisular , Transcripción Genética , Transfección , Tirosina/metabolismo , Proteína bcl-X
7.
Int Immunol ; 13(1): 105-17, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11133839

RESUMEN

The proximal promoter of lck directs gene expression exclusively in T cells. To investigate the developmental regulation of the lck proximal promoter activity and its relationship to T cell lineage commitment, a green fluorescence protein (GFP) transgenic (Tg) mouse in which the GFP expression is under the control of the proximal promoter of lck was created. In the adult GFP-Tg mice, >90% of CD4(+)CD8(+) and CD4(+)CD8(-) thymocytes, and the majority of CD4(-)CD8(+) and CD4(-)CD8(-) [double-negative (DN)] thymocytes were highly positive for GFP. Slightly lower but substantial levels of expression of GFP was also observed in mature splenic T cells. No GFP(+) cells was detected in non-T lineage subsets, including mature and immature B cells, CD5(+) B cells, and NK cells, indicating a preserved tissue specificity of the promoter. The earliest GFP(+) cells detected were found in the CD44(+)CD25(-) DN thymocyte subpopulation. The developmental potential of GFP(-) and GFP(+) cells in the CD44(+)CD25(-) DN fraction was examined using in vitro culture systems. The generation of substantial numbers of alphabeta and gammadelta T cells as well as NK cells was demonstrated from both GFP(-) and GFP(+) cells. However, no development of B cells or dendritic cells was detected from GFP(+) CD44(+)CD25(-) DN thymocytes. These results suggest that the progenitors expressing lck proximal promoter activity in the CD44(+)CD25(-) DN thymocyte subset have lost most of the progenitor potential for the B and dendritic cell lineage. Thus, progression of T cell lineage restriction in the earliest thymic population can be visualized by lck proximal promoter activity, suggesting a potential role of Lck in the T cell lineage commitment.


Asunto(s)
Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/biosíntesis , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/genética , Regiones Promotoras Genéticas/inmunología , Subgrupos de Linfocitos T/enzimología , Subgrupos de Linfocitos T/inmunología , Timo/citología , Timo/enzimología , Animales , Linfocitos B/citología , Diferenciación Celular/genética , Diferenciación Celular/inmunología , Linaje de la Célula/genética , Linaje de la Célula/inmunología , Células Cultivadas , Células Dendríticas/citología , Regulación de la Expresión Génica/inmunología , Proteínas Fluorescentes Verdes , Receptores de Hialuranos/biosíntesis , Células Asesinas Naturales/citología , Células Asesinas Naturales/metabolismo , Proteínas Luminiscentes/biosíntesis , Proteínas Luminiscentes/genética , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Microscopía Confocal , Receptores de Antígenos de Linfocitos T alfa-beta/biosíntesis , Receptores de Antígenos de Linfocitos T gamma-delta/biosíntesis , Receptores de Interleucina-2/biosíntesis , Escifozoos , Bazo/inmunología , Bazo/metabolismo , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/metabolismo , Timo/crecimiento & desarrollo , Timo/inmunología
8.
Oncology ; 58(4): 293-9, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10838494

RESUMEN

Transcatheter arterial embolization (TAE) has been widely performed for patients with hepatocellular carcinoma (HCC). However, the method of evaluating the therapeutic effect of TAE has not been established. We examined the rate of necrotic area to whole tumor (TN) by CT, the tumor regression rate (TR) and the reduction rate in serum alpha-fetoprotein (AFP) levels in patients with HCC who received hepatic resection within 3 months after TAE. In the evaluation of TN, the lipiodol accumulation in tumor was regarded as being necrotic. Rates of necrotic area, which were also examined pathologically (PN) in resected tumors, were compared with TN, TR and AFP reduction rates, respectively. Eighty-eight patients were enrolled in this study, and there was a significant positive correlation between TN and PN (r = 0.80, p < 0.001). Although TR significantly correlated to PN (p = 0.001), the correlation coefficient between them was low (r = 0.34). The correlation coefficients between AFP reduction rate and PN was 0.76 (p < 0.001) in 26 patients (30%) with an AFP level >/=200 ng/ml before TAE. The evaluation method using lipiodol accumulation in CT is the most useful for assessing the therapeutic effect of TAE, particularly when a sufficiently long interval exists between TAE and the evaluation, because of the highest correlation coefficient between TN and PN, and the availability of TN for all patients. The reduction rate in serum AFP levels was also useful in patients with AFP levels >200 ng/ml before treatment.


Asunto(s)
Carcinoma Hepatocelular/terapia , Embolización Terapéutica , Neoplasias Hepáticas/terapia , Adulto , Anciano , Carcinoma Hepatocelular/sangre , Carcinoma Hepatocelular/diagnóstico por imagen , Embolización Terapéutica/métodos , Femenino , Arteria Hepática , Humanos , Infusiones Intraarteriales , Aceite Yodado , Neoplasias Hepáticas/sangre , Neoplasias Hepáticas/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Necrosis , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , alfa-Fetoproteínas/metabolismo
9.
J Appl Physiol (1985) ; 88(5): 1590-6, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10797117

RESUMEN

To investigate how the sweating response to a sustained handgrip exercise depends on changes in the exercise intensity, the sweating response to exercise was measured in eight healthy male subjects. Each subject lay in the supine position in a climatic chamber (35 degrees C and 50% relative humidity) for approximately 60 min. This exposure caused sudomotor activation by increasing skin temperature without a marked change in internal temperature. After this period, each subject performed isometric handgrip exercise [15, 30, 45, and 60% maximal voluntary contraction (MVC)] for 60 s. Although esophageal and mean skin temperatures did not change with a rise in exercise intensity and were similar at all exercise intensities, the sweating rate (SR) on the forearm increased significantly (P < 0.05) from baseline (0.094 +/- 0.021 mg. cm(-2). min(-1) at 30% MVC, 0.102 +/- 0.022 mg. cm(-2). min(-1) at 45% MVC, 0.059 +/- 0.009 mg. cm(-2). min(-1) at 60% MVC) in parallel with exercise intensity above exercise intensity at 30% MVC (0.121 +/- 0.023 mg. cm(-2). min(-1) at 30% MVC, 0.242 +/- 0.051 mg. cm(-2). min(-1) at 45% MVC, 0.290 +/- 0.056 mg. cm(-2). min(-1) at 60% MVC). Above 45% MVC, SR on the palm increased significantly from baseline (P < 0.05). Although SR on the forearm and palm tended to increase with a rise in exercise intensity, there was a difference in the time courses of SR between sites. SR on the palm showed a plateau after abrupt increase, whereas SR on the forearm increased progressively during exercise. These results suggest that the increase in SR with the increase in sustained handgrip exercise intensity is due to nonthermal factors and that the magnitude of these factors during the exercise may be responsible for the magnitude of SR.


Asunto(s)
Ejercicio Físico/fisiología , Sudoración/fisiología , Adulto , Antebrazo/fisiología , Cabello/fisiología , Mano/fisiología , Fuerza de la Mano/fisiología , Calor , Humanos , Hipertermia Inducida , Contracción Isométrica/fisiología , Masculino , Músculo Esquelético/fisiología , Temperatura Cutánea/fisiología
10.
Neurosci Lett ; 282(1-2): 117-9, 2000 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-10713410

RESUMEN

We studied the extracellular concentration of glutamate and taurine in the frontal cortex of freely-moving pentylenetetrazole (PTZ) kindled rats using an in vivo microdialysis. A significant and sustained increase in the glutamate level was observed in the kindled rats, in contrast, a slight and delayed increase was observed in the non-kindled rats when the same grade seizure was induced by PTZ. The convulsive dose of PTZ administration caused a decrease in taurine levels in the controls, however, no significant changes were found in the kindled rats.


Asunto(s)
Espacio Extracelular/metabolismo , Lóbulo Frontal/metabolismo , Ácido Glutámico/metabolismo , Excitación Neurológica , Taurina/metabolismo , Animales , Convulsivantes , Masculino , Pentilenotetrazol , Ratas , Ratas Sprague-Dawley , Convulsiones/metabolismo
11.
Br Poult Sci ; 40(1): 127-30, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10405048

RESUMEN

1. We examined the effects of thiamine-hydrochloride (10 mg/kg body weight) and a beta-agonist, clenbuterol (50 microg/kg body weight), on plasma metabolites and hepatic oxygen consumption in female broiler chicks. 2. Clenbuterol, thiamine or both, dissolved in saline, were injected into thigh muscle on 2, 4 and 6 d of age. At 7 d of age blood samples in each treatment group were obtained and breast muscle and liver were weighed; liver slices were used for measurement of oxygen consumption. 3. Body weight gain was reduced by clenbuterol. Thiamine increased breast muscle weight as a proportion of body weight regardless of clenbuterol dose. Clenbuterol increased relative liver weight markedly, especially when chicks received thiamine also. 4. Clenbuterol increased plasma free fatty acid concentration in chicks treated with thiamine. Thiamine decreased plasma triglyceride regardless of clenbuterol dose. Plasma glucose concentration was decreased by both thiamine and clenbuterol. 5. The absolute rate of oxygen consumption in liver slices was greater in the thiamine-treated chicks; clenbuterol did not affect hepatic oxygen consumption. 6. These findings suggest that thiamine-induced energy expenditure results not only from thermogenesis in the liver, but also from increasing energy utilisation for muscle hypertrophy and this vitamin supplementation facilitates the lipolytic effects of the beta-agonist.


Asunto(s)
Glucemia/metabolismo , Composición Corporal/efectos de los fármacos , Clenbuterol/farmacología , Ácidos Grasos no Esterificados/sangre , Hígado/metabolismo , Consumo de Oxígeno/efectos de los fármacos , Tiamina/farmacología , Triglicéridos/sangre , Agonistas Adrenérgicos beta/administración & dosificación , Agonistas Adrenérgicos beta/farmacología , Animales , Pollos , Clenbuterol/administración & dosificación , Femenino , Inyecciones Intramusculares , Hígado/efectos de los fármacos , Hígado/crecimiento & desarrollo , Desarrollo de Músculos , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/crecimiento & desarrollo , Tamaño de los Órganos/efectos de los fármacos , Tiamina/administración & dosificación , Aumento de Peso/efectos de los fármacos
12.
J Inherit Metab Dis ; 22(2): 155-62, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10234611

RESUMEN

Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive neurodegenerative disorder that affects both the central and peripheral nervous system due to an enzymatic defect of galactocerebrosidase (GALC). Following its cloning, many mutations in the galactocerebrosidase gene have been reported, but the correlation between phenotype and genotype was not clear in many cases. In this study we further investigated the molecular defects in another 10 patients (6 Japanese and 4 non-Japanese), using cultured skin fibroblasts, and found 10 mutations, of which 8 were novel, including a nonsense mutation (W647X) and 7 missense mutations (G43R, S52F, T262I, Y319C. W410G, R515H, T652R) in the coding region. Some phenotype-specific mutations were found but the other mutations were private. Mutations reported so far have been distributed over the whole GALC gene and it is difficult to speculate on functional domains of the GALC protein and phenotypically specific regions.


Asunto(s)
Galactosilceramidasa/genética , Leucodistrofia de Células Globoides/enzimología , Leucodistrofia de Células Globoides/genética , Alanina/genética , Animales , Northern Blotting , Células COS , ADN Complementario , Eliminación de Gen , Heterogeneidad Genética , Glicina/genética , Humanos , Mutagénesis , Polimorfismo Genético
13.
Biosci Biotechnol Biochem ; 63(12): 2045-52, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10664836

RESUMEN

We investigated the ergogenic effect in mice of administering highly branched cyclic dextrin (HBCD), a new type of glucose polymer, on the swimming endurance in an adjustable-current swimming pool. Male Std ddY mice were administered a HBCD, a glucose solution or water via a stomach sonde 10 min before, 10 min after or 30 min after beginning swimming exercise, and were then obliged to swim in the pool. The total swimming period until exhaustion, an index of the swimming endurance, was measured. An ergogenic effect of HBCD was observed at a dose of 500 mg/kg of body weight, whereas it had no effect at a dose of 166 mg/kg of body wt (p < 0.05). The mice administered with the HBCD solution 10 min after starting the exercise were able to swim significantly longer (p < 0.05) than the mice who had ingested water or the glucose solution. The rise in mean blood glucose level in the mice administered with HBCD, which was measured 20 min after starting swimming, was significantly lower (p < 0.05) than that in the mice administered with glucose, although it was significantly higher (p < 0.05) than that in the mice administered with water. The mean blood insulin rise in the mice given HBCD was significantly lower (p < 0.05) than that in the mice given glucose. The mice administered with HBCD 30 min after starting the exercise swam significantly longer (p < 0.05) than the mice who had ingested water, although the enhancement of swimming time was similar to that of the glucose-ingesting mice. The gastric emptying rate of the HBCD solution was significantly faster (p < 0.05) than that of the glucose solution. However, this glucose polymer must have spent more time being absorbed because it has to be hydrolyzed before absorption, reflecting a lower and possibly longer-lasting blood glucose level. We conclude that the prolongation of swimming endurance in mice administered with HBCD depended on its rapid and longer-lasting ability for supplying glucose with a lower postprandial blood insulin response, leading to a delayed onset of fatigue.


Asunto(s)
Dextrinas/farmacología , Condicionamiento Físico Animal , Resistencia Física/efectos de los fármacos , Natación , Animales , Glucemia/metabolismo , Suplementos Dietéticos , Insulina/sangre , Masculino , Ratones , Relación Estructura-Actividad
14.
J Clin Endocrinol Metab ; 83(11): 3936-42, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9814472

RESUMEN

Hypophosphatasia is associated with a defect of the tissue-nonspecific alkaline phosphatase (TNSALP) gene. The onset and clinical severity are usually correlated in hypophosphatasia; patients with perinatal hypophosphatasia die approximately at the time of birth. In contrast, we describe a male neonatal patient with hypophosphatasia who had no respiratory problems and survived. He was compound heterozygous for the conversion of Phe to Leu at codon 310 (F310L) and the deletion of a nucleotide T at 1735 (delT1735), causing the frame shift with the result of the addition of 80 amino acids at the C-terminal of the protein. Because the C-terminal portion of TNSALP is known to be important for TNSALP to bind to the plasma membrane, the localization of wild-type and mutated TNSALP proteins was analyzed using green fluorescent protein chimeras. The expression vectors containing the complementary DNA of fusion proteins consisting of signal peptide, green fluorescent protein, and wild-type or mutated TNSALP, caused by delT1735 or F310L mutation, were introduced transiently or stably in Saos-2 cells. The delT1735 mutant failed to localize at the cell surface membrane, whereas the wild-type and the F310L mutants were located in the plasma membrane and cytoplasm. The assay for enzymatic activity of TNSALP revealed that the delT1735 mutant lost the activity and that the F310L mutant exhibited an enzymatic activity level that was 72% of the normal level. The F310L mutation was also detected in another neonatal patient with relatively mild (nonlethal) hypophosphatasia (reported in J Clin Endocrinol Metab, 81:4458-4461, 1996), suggesting that residual ALP activity of the F310L mutant contributes to the less severe phenotype. The patient is unique, with respect to a discrepancy between onset and clinical severity in hypophosphatasia.


Asunto(s)
Fosfatasa Alcalina/genética , Mutación del Sistema de Lectura , Hipofosfatasia/genética , Fosfatasa Alcalina/análisis , Sustitución de Aminoácidos , Femenino , Eliminación de Gen , Proteínas Fluorescentes Verdes , Humanos , Indicadores y Reactivos , Recién Nacido , Leucina , Proteínas Luminiscentes , Masculino , Especificidad de Órganos , Fenilalanina , Polimorfismo Genético , Proteínas Recombinantes de Fusión
15.
Mol Cell Biol ; 18(7): 4235-44, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9632807

RESUMEN

The BCL6 gene, which has been identified from the chromosomal translocation breakpoint in B-cell lymphomas, functions as a sequence-specific transcriptional repressor. We cloned a novel Bcl6-homologous gene, BAZF (encoding Bcl6-associated zinc finger protein). The predicted amino acid sequence of BAZF indicated that the BTB/POZ domain and the five repeats of the Krüppel-like zinc finger motif are located in the NH2-terminal region and the COOH-terminal region, respectively. BAZF associated with Bcl6 at the BTB/POZ domain and localized in the nucleus. Since zinc finger motifs of BAZF were 94% identical to those of Bcl6 at the amino acid level, BAZF bound specifically to the DNA-binding sequence of Bcl6 and functioned as a transcriptional repressor. The repressor activity was associated with both the BTB/POZ domain and the middle portion of BAZF. The 17-amino-acid sequence in the middle portion was completely conserved between BAZF and Bcl6, and the conserved region was critical for the repressor activity. Expression of BAZF mRNA, like that of Bcl6 mRNA, was induced in activated lymphocytes as an immediate-early gene. Therefore, the biochemical character of BAZF is similar to that of Bcl6 although the tissue expression pattern of BAZF differs from that of Bcl6. This is apparently the first report of a gene family whose members encode zinc finger proteins with the BTB/POZ domain.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Represoras/fisiología , Factores de Transcripción/metabolismo , Transcripción Genética , Dedos de Zinc , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Núcleo Celular/metabolismo , Clonación Molecular , ADN Complementario , Proteínas de Unión al ADN/genética , Femenino , Expresión Génica , Genes Inmediatos-Precoces , Pulmón/metabolismo , Linfocitos/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Datos de Secuencia Molecular , Miocardio/metabolismo , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-bcl-6 , ARN Mensajero , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Factores de Transcripción/genética
16.
Biochem Biophys Res Commun ; 247(2): 493-7, 1998 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-9642157

RESUMEN

Potato D-enzyme catalyses an intramolecular transglycosylation reaction on amylose to produce cycloamylose, a novel cyclic alpha-1, 4 glucan. To determine if a similar activity could be observed with a high molecular weight branched substrate, recombinant potato D-enzyme was incubated with amylopectin. The substrate was converted into two fractions of lower molecular mass. Fraction I comprised 15% cyclic molecules of which the majority contained both alpha-1,4 and alpha-1,6 links. These were shown to be branched molecules with branches shorter than those in amylopectin. Fraction II comprised 80% cyclic molecules of which the majority contained only alpha-1,4 links (cycloamylose). Since fraction II appeared before fraction I, we propose that D-enzyme first catalysed the cyclisation of the outer side chains of amylopectin and then the cyclisation of inner chains to produce branched clusters. These results demonstrate that D-enzyme can catalyse the transfer of branched glucans, and suggest novel ways in which it may participate in starch metabolism in plants.


Asunto(s)
Amilopectina/metabolismo , Glucanos/biosíntesis , Sistema de la Enzima Desramificadora del Glucógeno/metabolismo , Amilopectina/química , Glucano 1,4-alfa-Glucosidasa/metabolismo , Glucanos/química , Glicosilación , Modelos Biológicos , Peso Molecular , Plantas/metabolismo , Solanum tuberosum/enzimología , Almidón/metabolismo
17.
Nihon Rinsho ; 56(1): 208-12, 1998 Jan.
Artículo en Japonés | MEDLINE | ID: mdl-9465692

RESUMEN

In our all patients, the antibodies to HHV-6 and -7 were positive before BMT. HHV -6 and -7 DNA were sometimes detected after BMT, and HHV-6 infection after BMT caused fever, interstitial peumonitis, diarrhea, and myelosuppression. However, HHV -7 didn't induce any clinical symptoms. For the diagnosis of the HHV-6 or -7 infection, we used the virus isolation, semiquantitative PCR, and 4-hold elevation of the antibodies to HHV-6 or -7. Ganciclovir, foscarnet, high dose gamma-globulin and high dose acyclovir were useful for the treatment of HHV-6 infection after BMT. HHV-6 is an important agent for the fever of unknown origin, interstitial peumonitis, diarrhea, and myelosuppression after BMT.


Asunto(s)
Trasplante de Médula Ósea/efectos adversos , Infecciones por Herpesviridae/diagnóstico , Herpesvirus Humano 6 , Herpesvirus Humano 7 , Aciclovir/uso terapéutico , Anticuerpos Antivirales/análisis , Antivirales/uso terapéutico , Foscarnet/uso terapéutico , Ganciclovir/uso terapéutico , Infecciones por Herpesviridae/tratamiento farmacológico , Infecciones por Herpesviridae/virología , Herpesvirus Humano 6/inmunología , Herpesvirus Humano 6/aislamiento & purificación , Herpesvirus Humano 7/inmunología , Herpesvirus Humano 7/aislamiento & purificación , Humanos , Huésped Inmunocomprometido , Reacción en Cadena de la Polimerasa , gammaglobulinas/administración & dosificación
18.
Biochim Biophys Acta ; 1395(1): 62-7, 1998 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-9434153

RESUMEN

Galactocerebrosidase (GALC; EC 3.2.1.46) is a lysosomal enzyme which hydrolyzes several galactolipids and the deficiency of GALC is responsible for Krabbe disease. Recently, we cloned cDNAs for human and murine GALC. In this study we characterized the genomic organization and the promoter of the human gene. The gene was about 60 kb in length and consisted of 17 exons as reported by Luzi et al. DNA sequence analysis showed that the 5'-flanking region of the first exon was GC-rich and had not typical TATA-box but ten GC-box-like sequences within a 200 bp sequence upstream from the initiation codon. Another inframe ATG, which has better Kozak consensus sequence, was found at 48 bp upstream to the first ATG reported]. Promoter analysis using a luciferase assay in COS 7 cells showed that the -149 to -112 nucleotide (from the initiation codon A) region has dominant promoter activity. In this region three GC-box-like sequence and one YY1 binding site were detected. Primer extension revealed several transcription start sites within the region of -146 to -103 nucleotide. In this study we firstly demonstrated that the YY1 binding site and subsequent GC-box-like sequences could be a promoter in a housekeeping gene.


Asunto(s)
Galactosilceramidasa/genética , Genes/genética , Regiones Promotoras Genéticas/genética , Animales , Secuencia de Bases , Sitios de Unión , Células COS , Clonación Molecular , Proteínas de Unión al ADN , Factores de Unión al ADN Específico de las Células Eritroides , Exones/genética , Humanos , Datos de Secuencia Molecular , Proteínas Recombinantes de Fusión , Análisis de Secuencia de ADN , Factores de Transcripción , Transcripción Genética/genética , Factor de Transcripción YY1
19.
Pathol Int ; 47(11): 748-56, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9413033

RESUMEN

The causality of vascular and parenchymal damage to the central nervous system (CNS) was examined in rats with thiamine deficiency. Male Sprague-Dawley rats were divided into two groups; one was given a thiamine-deficient diet (TDD) and injected intraperitoneally with 10 micrograms/100 g bodyweight pyrithiamine (PT) in order to analyze morphometrically the topographical and sequential relationship between vascular and parenchymal changes and vasodilatation, and the other was given a TDD and 50 micrograms/100 g bodyweight PT in order to determine hemorrhagic sites using serial sections. Histological examination showed that spongiotic change occurred selectively in the inferior colliculus (100%) from day 19, and thereafter in the thalamus (95%), mammillary body (50%) and nuclei olivaris and vestibularis of the pons (25%), with or without hemorrhage. Simultaneously, glycogen accumulation was also observed in these regions at a frequency similar to that of hemorrhage. Ultrastructurally, however, hydropic swelling of astrocytic and neuronal processes without glycogen accumulation was observed as early as day 9 in the inferior colliculus, at which time an increase of glial fibrillary acidic protein-positive processes was also recognized. The superior colliculus was completely spared. From day 22 vasodilatation of the inferior colliculus occurred, concomitantly with bodyweight loss and neurological symptoms. Twenty-two examined hemorrhages, which occurred in the thalamus and inferior colliculus, were distributed along the arterioles or capillaries on the arterial side. In conclusion, the morphological CNS changes caused by thiamine deficiency with administration of low-dose PT in rats begin as hydropic swelling of neuronal and astrocytic processes, followed by hemorrhage and, thereafter, by vasodilation. The predilection for hemorrhage on the arterial side without parenchymal changes suggests that petechial hemorrhage is not simply secondary to parenchymal changes, but is due to hemodynamic change resulting from thiamine deficiency-induced vascular dysfunction.


Asunto(s)
Encéfalo/patología , Deficiencia de Tiamina/patología , Encefalopatía de Wernicke/patología , Animales , Antimetabolitos , Ataxia/inducido químicamente , Peso Corporal/efectos de los fármacos , Encéfalo/irrigación sanguínea , Hemorragia Cerebral/patología , Proteína Ácida Fibrilar de la Glía/análisis , Glucógeno/metabolismo , Hipotermia/inducido químicamente , Inmunohistoquímica , Colículos Inferiores/irrigación sanguínea , Colículos Inferiores/química , Colículos Inferiores/patología , Colículos Inferiores/ultraestructura , Masculino , Tubérculos Mamilares/irrigación sanguínea , Tubérculos Mamilares/patología , Piritiamina , Ratas , Ratas Sprague-Dawley , Convulsiones/inducido químicamente , Tálamo/irrigación sanguínea , Tálamo/patología , Vasodilatación/efectos de los fármacos , Encefalopatía de Wernicke/etiología
20.
Psychiatry Clin Neurosci ; 51(4): 207-12, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9316165

RESUMEN

A 51-year-old Japanese woman who had been suffering from a rapid cycling affective disorder (RCAD) for 24 years responded to combined clonazepam and carbamazepine therapy. Before remission, she showed neuroendocrinological and neuroimaging abnormalities such as subclinical hypothyroidism with exaggerated response to thyrotropin releasing hormone (TRH) injection, non-suppression on the dexamethasone suppression test (DST) and hypofrontality in cerebral blood flow. Her symptoms improved remarkably soon after adjunctive clonazepam treatment. After remission, her biological markers gradually returned to normal. First, subclinical hypothyroidism improved 2 months after remission. Next, hypofrontality disappeared 18 months later. Furthermore, non-suppression on the DST normalized 24 months later. The normalization of biological markers with apparent recovery from RCAD suggests a decreased risk of relapse into mood disorder. These findings reiterate the importance of following-up on the biological markers in RCAD for years after remission.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Trastorno Bipolar/tratamiento farmacológico , Carbamazepina/administración & dosificación , Clonazepam/administración & dosificación , Dexametasona , Lóbulo Frontal/irrigación sanguínea , Hidrocortisona/sangre , Hormona Liberadora de Tirotropina , Tirotropina/sangre , Tomografía Computarizada de Emisión de Fotón Único , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/fisiopatología , Quimioterapia Combinada , Femenino , Humanos , Hipotiroidismo/diagnóstico , Hipotiroidismo/tratamiento farmacológico , Hipotiroidismo/fisiopatología , Persona de Mediana Edad , Flujo Sanguíneo Regional/fisiología , Pruebas de Función de la Tiroides , Hormonas Tiroideas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA